Literature DB >> 17564716

Polymorphism of the prolactin extrapituitary promoter in psoriatic arthritis.

Jirí Stolfa, Markéta Fojtíková, Pavlína Cejková, Marie Cerná, Liliana Sedová, Ctibor Dostál.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17564716     DOI： 10.1007/s00296-007-0360-3

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  10 in total

1.  Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis.

Authors:  R P Donn; A Farhan; A Stevans; A Ramanan; W E R Ollier; W Thomson
Journal:  Rheumatology (Oxford)       Date:  2002-08       Impact factor: 7.580

2.  Characterization of a prolactin gene polymorphism and its associations with systemic lupus erythematosus.

Authors:  A Stevens; D Ray; A Alansari; A Hajeer; W Thomson; R Donn; W E Ollier; J Worthington; J R Davis
Journal:  Arthritis Rheum       Date:  2001-10

3.  What is the best treatment approach for a patient with the mutilating pattern of psoriatic peripheral arthritis?

Authors:  V Wright
Journal:  Br J Rheumatol       Date:  1989-10

Review 4.  Polymorphisms of the human prolactin gene--implications for production of lymphocyte prolactin and systemic lupus erythematosus.

Authors:  A Stevens; D W Ray; J Worthington; J R Davis
Journal:  Lupus       Date:  2001       Impact factor: 2.911

5.  Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis.

Authors:  H Nagafuchi; N Suzuki; A Kaneko; T Asai; T Sakane
Journal:  J Rheumatol       Date:  1999-09       Impact factor: 4.666

6.  Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia.

Authors:  D Buskila; S Sukenik; G Holcberg; J Horowitz
Journal:  J Rheumatol       Date:  1991-04       Impact factor: 4.666

7.  Prolactin: does it have a role in the pathogenesis of psoriasis?

Authors:  A S Giasuddin; A I El-Sherif; S I El-Ojali
Journal:  Dermatology       Date:  1998       Impact factor: 5.366

8.  Serum free prolactin concentrations in patients with systemic lupus erythematosus are associated with lupus activity.

Authors:  A Leaños-Miranda; G Cárdenas-Mondragón
Journal:  Rheumatology (Oxford)       Date:  2005-10-25       Impact factor: 7.580

Review 9.  Bromocriptine in rheumatic and autoimmune diseases.

Authors:  R W McMurray
Journal:  Semin Arthritis Rheum       Date:  2001-08       Impact factor: 5.532

10.  Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma.

Authors:  B Gellersen; R Kempf; R Telgmann; G E DiMattia
Journal:  Mol Endocrinol       Date:  1994-03
  10 in total
  2 in total

1.  The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility.

Authors:  Yvonne C Lee; Soumya Raychaudhuri; Jing Cui; Immaculata De Vivo; Bo Ding; Lars Alfredsson; Leonid Padyukov; Karen H Costenbader; Mark Seielstad; Robert R Graham; Lars Klareskog; Peter K Gregersen; Robert M Plenge; Elizabeth W Karlson
Journal:  Arthritis Rheum       Date:  2009-05

2.  Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus.

Authors:  Jorge Hernández-Bello; Claudia A Palafox-Sanchez; Samuel García-Arellano; Zyanya Reyes-Castillo; Ana L Pereira-Suárez; Isela Parra-Rojas; José E Navarro-Zarza; Ulises De la Cruz-Mosso; Nora M Torres-Carrillo; José Francisco Muñoz-Valle
Journal:  Arch Med Sci       Date:  2016-09-02       Impact factor: 3.318
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.